Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06419218 · ClinicalTrials.gov registry record · NA
Increasing School Meal Participation
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 832
- Enrollment target
NCT06419218: Completed NA study, sponsored by Stanford University.
NCT06419218 is a NA study that has completed, run by Stanford University. The registered enrollment target is 832 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (41% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06419218, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 832 participants
- Enrollment target
Study Summary
This study aims to determine whether an online marketing campaign increases children's school meal participation. Parents whose children do not currently eat school meals frequently will be exposed to messages designed to encourage their children's increased participation in school meals.
Primary Outcome
Parental report of the usual number of days per week their child ate school lunch during the past month. Assessed with 1 item: "Thinking about the last month, how many days a week did your child usually eat school lunch?" This item will be scored on a 6-point scale from "0 days per week" (0) to "5 days per week" (5).
Interventions
- BEHAVIORAL School meal messages
- BEHAVIORAL Control (neutral) messages
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 832 participants |
| Start Date | 2024-09-19 |
| Est. Completion | 2024-12-20 |
| Phase | NA |
What the finished NCT06419218 record still lists
NCT06419218 is an interventional study that assigns participants to a tested intervention. The registered 832 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (41% lower).
The record links to 0 conditions, and to 2 interventions - of which School meal messages is the first listed.
NCT06419218 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06419218 about?
NCT06419218 is a clinical study titled "Increasing School Meal Participation". This study aims to determine whether an online marketing campaign increases children's school meal participation. Parents whose children do not currently eat school meals frequently will be exposed to messages designed to encourage their children's increased participation in school meals.
What is the current status of trial NCT06419218?
This trial is currently completed. It is a NA study. The enrollment target is 832 participants. The study started on 2024-09-19. Estimated completion is 2024-12-20.
What interventions are being tested in trial NCT06419218?
The interventions under investigation include: School meal messages (BEHAVIORAL), Control (neutral) messages (BEHAVIORAL).
Who is sponsoring clinical trial NCT06419218?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06419218's enrollment target sits among peer trials
832 134th of 2000 higher than 1,867 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06910553 · 832 participants
IBD Pregnancy Registry
- NCT07089706 · 832 participants · Phase 4
A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations
- NCT05067283 · 830 participants · Phase 1
A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)
- NCT06592924 · 830 participants · Phase 3
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI